Enanta Pharmaceuticals Inc

CUSIP: 29251m106 Class: COM

Convergence Investment Partners, LLC's Holding History (CIK: 0001456133)

Note: Option positions (PUT/CALL) are excluded.

Q2 2015
Shares 51,840 Value ($000) $2,332 Avg Close — Range —
Q3 2014
Shares 53,130 Value ($000) $2,102 Avg Close — Range —